{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T11:05:22Z","timestamp":1789643122581,"version":"4.0.0"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,5,10]],"date-time":"2016-05-10T00:00:00Z","timestamp":1462838400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100007137","name":"Helse Nord RHF (NO)","doi-asserted-by":"publisher","award":["SFP 1079-12"],"award-info":[{"award-number":["SFP 1079-12"]}],"id":[{"id":"10.13039\/501100007137","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cardiovasc Disord"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1186\/s12872-016-0265-8","type":"journal-article","created":{"date-parts":[[2016,5,9]],"date-time":"2016-05-09T22:42:09Z","timestamp":1462833729000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":45,"title":["Overweight modifies the longitudinal association between uric acid and some components of the metabolic syndrome: The Troms\u00f8 Study"],"prefix":"10.1186","volume":"16","author":[{"given":"Jon V.","family":"Norvik","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hilde M.","family":"Storhaug","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirsti","family":"Ytrehus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trond G.","family":"Jenssen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Svetlana N.","family":"Zykova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bj\u00f8rn O.","family":"Eriksen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marit D.","family":"Solbu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,5,10]]},"reference":[{"key":"265_CR1","doi-asserted-by":"publisher","first-page":"3136","DOI":"10.1002\/art.30520","volume":"63","author":"Y Zhu","year":"2011","unstructured":"Zhu Y, Pandya BJ, Choi HK. Prevalence of gout and hyperuricemia in the US general population: The National Health and Nutrition Examination Survey 2007\u20132008. Arthritis Rheum. 2011;63:3136\u201341.","journal-title":"Arthritis Rheum"},{"key":"265_CR2","first-page":"1346","volume":"33","author":"H Nan","year":"2006","unstructured":"Nan H, Qiao Q, Dong Y, Gao W, Tang B, Qian R, et al. The prevalence of hyperuricemia in a population of the coastal city of Qingdao, China. J Rheumatol. 2006;33:1346\u201350.","journal-title":"J Rheumatol"},{"key":"265_CR3","doi-asserted-by":"publisher","unstructured":"Kuo C-F, Grainge MJ, Zhang W, Doherty M. Global epidemiology of gout: prevalence, incidence and risk factors. Nat. Rev. Rheumatol. Nature Publishing Group; 2015;11:649-662. doi: 10.1038\/nrrheum.2015.91 .","DOI":"10.1038\/nrrheum.2015.91"},{"key":"265_CR4","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1002\/art.23177","volume":"58","author":"CG Helmick","year":"2008","unstructured":"Helmick CG, Felson DT, Lawrence RC, Gabriel S, Hirsch R, Kwoh CK, et al. Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part I. Arthritis Rheum. 2008;58:15\u201325.","journal-title":"Arthritis Rheum"},{"key":"265_CR5","doi-asserted-by":"publisher","first-page":"2735","DOI":"10.1161\/CIRCULATIONAHA.105.169404","volume":"112","author":"SM Grundy","year":"2005","unstructured":"Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, et al. Diagnosis and management of the metabolic syndrome: an American Heart Association\/National Heart, Lung, and Blood Institute scientific statement. Circulation. 2005;112:2735\u201352.","journal-title":"Circulation"},{"key":"265_CR6","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1016\/j.jacc.2010.05.034","volume":"56","author":"S Mottillo","year":"2010","unstructured":"Mottillo S, Filion KB, Genest J, Joseph L, Pilote L, Poirier P, et al. The metabolic syndrome and cardiovascular risk: a systematic review and meta-analysis. J Am Coll Cardiol. 2010;56:1113\u201332.","journal-title":"J Am Coll Cardiol"},{"key":"265_CR7","unstructured":"Ervin RB. Prevalence of metabolic syndrome among adults 20 years of age and over, by sex, age, race and ethnicity, and body mass index: United States, 2003\u20132006. Natl. Health Stat. Report. 2009;13:1-7. http:\/\/www.cdc.gov\/nchs\/data\/nhsr\/nhsr013.pdf ."},{"key":"265_CR8","doi-asserted-by":"crossref","unstructured":"Kaur J. A comprehensive review on metabolic syndrome. Cardiol Res Pract. 2014;2014. http:\/\/dx.doi.org\/10.1155\/2014\/943162 .","DOI":"10.1155\/2014\/943162"},{"key":"265_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2337\/dc10-1990","volume":"34","author":"A Mozundar","year":"2011","unstructured":"Mozundar A, Liguori G. Persistent increase of prevalence of metabolic syndrome among U.S. adults: NHANES III to NHANES 1999\u20132006. Diabetes Care. 2011;34:1\u20134.","journal-title":"Diabetes Care"},{"key":"265_CR10","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1016\/S0140-6736(10)62037-5","volume":"377","author":"MM Finucane","year":"2011","unstructured":"Finucane MM, Stevens GA, Cowan MJ, Danaei G, Lin JK, Paciorek CJ, et al. National, regional, and global trends in body-mass index since 1980: systematic analysis of health examination surveys and epidemiological studies with 960 country-years and 9.1 million participants. Lancet. 2011;377:557\u201367.","journal-title":"Lancet"},{"key":"265_CR11","doi-asserted-by":"publisher","first-page":"1431","DOI":"10.1038\/ijo.2008.102","volume":"32","author":"T Kelly","year":"2008","unstructured":"Kelly T, Yang W, Chen C-S, Reynolds K, He J. Global burden of obesity in 2005 and projections to 2030. Int J Obes. 2008;32:1431\u20137.","journal-title":"Int J Obes"},{"key":"265_CR12","doi-asserted-by":"publisher","first-page":"2404","DOI":"10.1001\/jama.283.18.2404","volume":"283","author":"J Fang","year":"2000","unstructured":"Fang J, Alderman M. Serum uric acid and cardiovascular mortality: the NHANES I epidemiologic follow-up study, 1971\u20131992. J Am Med Assoc. 2000;283:2404\u201310.","journal-title":"J Am Med Assoc"},{"key":"265_CR13","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1111\/j.1365-2796.2009.02133.x","volume":"266","author":"I Holme","year":"2009","unstructured":"Holme I, Aastveit AH, Hammar N, Jungner I, Walldius G. Uric acid and risk of myocardial infarction, stroke and congestive heart failure in 417 734 men and women in the Apolipoprotein MOrtality RISk study (AMORIS). J Intern Med. 2009;266:558\u201370.","journal-title":"J Intern Med"},{"key":"265_CR14","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1186\/1471-2261-13-115","volume":"13","author":"HM Storhaug","year":"2013","unstructured":"Storhaug HM, Norvik JV, Toft I, Eriksen BO, L\u00f8chen M-L, Zykova S, et al. Uric acid is a risk factor for ischemic stroke and all-cause mortality in the general population: a gender specific analysis from The Troms\u00f8 Study. BMC Cardiovasc Disord. 2013;13:115.","journal-title":"BMC Cardiovasc Disord"},{"key":"265_CR15","doi-asserted-by":"publisher","first-page":"7","DOI":"10.7326\/0003-4819-131-1-199907060-00003","volume":"131","author":"BF Culleton","year":"1999","unstructured":"Culleton BF, Larson MG, Kannel WB, Levy D. Serum uric acid and risk for cardiovascular disease and death: the Framingham Heart Study. Ann Intern Med. 1999;131:7\u201313.","journal-title":"Ann Intern Med"},{"key":"265_CR16","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1002\/acr.20344","volume":"63","author":"PC Grayson","year":"2011","unstructured":"Grayson PC, Young Kim S, Lavalley M, Choi HK. Hyperuricemia and incident hypertension: a systematic review and meta-analysis. Arthritis Care Res. 2011;63:102\u201310.","journal-title":"Arthritis Care Res"},{"key":"265_CR17","doi-asserted-by":"crossref","unstructured":"Zhang Q, Zhang C, Song X, Lin H, Zhang D, Meng W, et al. A longitudinal cohort based association study between uric acid level and metabolic syndrome in Chinese Han urban male population. BMC Public Health. 2012;12:419.","DOI":"10.1186\/1471-2458-12-419"},{"key":"265_CR18","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1016\/S1726-4901(09)70320-X","volume":"69","author":"S-D Lin","year":"2006","unstructured":"Lin S-D, Tsai D-H, Hsu S-R. Association between serum uric acid level and components of the metabolic syndrome. J Chin Med Assoc. 2006;69:512\u20136.","journal-title":"J Chin Med Assoc"},{"key":"265_CR19","first-page":"2007","volume":"31","author":"A Dehghan","year":"2008","unstructured":"Dehghan A, Van Hoek M, Sijbrands EJG, Hofman A, Wetteman JCM. High serum uric acid as a novel risk factor for type 2 diabetes. Cardiovasc Metab Risk. 2008;31:2007\u20138.","journal-title":"Cardiovasc Metab Risk"},{"key":"265_CR20","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1016\/j.amjmed.2006.06.040","volume":"120","author":"HK Choi","year":"2007","unstructured":"Choi HK, Ford ES. Prevalence of the metabolic syndrome in individuals with hyperuricemia. Am J Med. 2007;120:442\u20137.","journal-title":"Am J Med"},{"key":"265_CR21","doi-asserted-by":"publisher","first-page":"181","DOI":"10.3961\/jpmph.2012.45.3.181","volume":"45","author":"J-M Lee","year":"2012","unstructured":"Lee J-M, Kim HC, Cho HM, Oh SM, Choi DP, Suh I. Association between serum uric acid level and metabolic syndrome. J Prev Med Public Health. 2012;45:181.","journal-title":"J Prev Med Public Health"},{"key":"265_CR22","first-page":"155","volume":"5","author":"A Ziaee","year":"2013","unstructured":"Ziaee A, Esmailzadehha N, Ghorbani A, Asefzadeh S. Association between uric acid and metabolic syndrome in Qazvin Metabolic Diseases Study (QMDS), Iran. Glob J Health Sci. 2013;5:155\u201365.","journal-title":"Glob J Health Sci"},{"key":"265_CR23","doi-asserted-by":"publisher","first-page":"1360","DOI":"10.1016\/j.numecd.2014.06.002","volume":"24","author":"LA Ferrara","year":"2014","unstructured":"Ferrara LA, Wang H, Umans JG, Franceschini N, Jolly S, Lee ET, et al. Serum uric acid does not predict incident metabolic syndrome in a population with high prevalence of obesity. Nutr Metab Cardiovasc Dis. 2014;24:1360\u20134.","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"265_CR24","doi-asserted-by":"publisher","first-page":"4198","DOI":"10.1210\/jc.2015-2527","volume":"100","author":"H Yuan","year":"2015","unstructured":"Yuan H, Yu C, Li X, Sun L, Zhu X, Zhao C, et al. Serum uric acid levels and risk of metabolic syndrome: a dose\u2013response meta-analysis of prospective studies. J Clin Endocrinol Metab. 2015;100:4198\u2013207.","journal-title":"J Clin Endocrinol Metab"},{"key":"265_CR25","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1093\/ije\/dyr049","volume":"41","author":"BK Jacobsen","year":"2012","unstructured":"Jacobsen BK, Eggen AE, Mathiesen EB, Wilsgaard T, Nj\u00f8lstad I. Cohort profile: the Troms\u00f8 study. Int J Epidemiol. 2012;41:961\u20137.","journal-title":"Int J Epidemiol"},{"key":"265_CR26","doi-asserted-by":"publisher","first-page":"2818","DOI":"10.1093\/ndt\/gfn148","volume":"23","author":"J Kronborg","year":"2008","unstructured":"Kronborg J, Solbu M, Nj\u00f8lstad I, Toft I, Eriksen BO, Jenssen T. Predictors of change in estimated GFR: a population-based 7-year follow-up from the Troms\u00f8 study. Nephrol Dial Transplant. 2008;23:2818\u201326.","journal-title":"Nephrol Dial Transplant"},{"key":"265_CR27","doi-asserted-by":"publisher","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","volume":"150","author":"AS Levey","year":"2009","unstructured":"Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF, Feldman HI, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150:604\u201312.","journal-title":"Ann Intern Med"},{"key":"265_CR28","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1007\/s10654-010-9540-7","volume":"26","author":"J Joseph","year":"2011","unstructured":"Joseph J, Svartberg J, Nj\u00f8lstad I, Schirmer H. Risk factors for type 2 diabetes in groups stratified according to metabolic syndrome: a 10-year follow-up of the Troms\u00f8 Study. Eur J Epidemiol. 2011;26:117\u201324.","journal-title":"Eur J Epidemiol"},{"key":"265_CR29","doi-asserted-by":"crossref","unstructured":"Cholesterol N, Program E. Metabolic Syndrome vs Framingham Risk Score for Prediction of Coronary Heart Disease, Stroke, and Type 2 Diabetes Mellitus. Arch Intern Med. 2005;165:2644\u201350.","DOI":"10.1001\/archinte.165.22.2644"},{"key":"265_CR30","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.numecd.2014.10.006","volume":"25","author":"N Babio","year":"2015","unstructured":"Babio N, Mart\u00ednez-Gonz\u00e1lez MA, Estruch R, W\u00e4rnberg J, Recondo J, Ortega-Calvo M, et al. Associations between serum uric acid concentrations and metabolic syndrome and its components in the PREDIMED study. Nutr Metab Cardiovasc Dis. 2015;25:173\u201380.","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"265_CR31","unstructured":"Lee J, Ryoo J, Choi J, Park SK. Serum uric acid level and the incidence of metabolic syndrome in middle-aged Korean men: a 5-year follow- up study. J Prev Med Public Health. 2014;47(6):317-26."},{"key":"265_CR32","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1007\/s00380-013-0386-2","volume":"29","author":"E Oda","year":"2014","unstructured":"Oda E. Serum uric acid is an independent predictor of metabolic syndrome in a Japanese health screening population. Heart Vessels. 2014;29:496\u2013503.","journal-title":"Heart Vessels"},{"key":"265_CR33","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1089\/met.2008.0045","volume":"7","author":"AR Abdullah","year":"2009","unstructured":"Abdullah AR, Hasan HA, Raigangar VL. Analysis of the relationship of leptin, high-sensitivity C-reactive protein, adiponectin, insulin, and uric acid to metabolic syndrome in lean, overweight, and obese young females. Metab Syndr Relat Disord. 2009;7:17\u201322.","journal-title":"Metab Syndr Relat Disord"},{"key":"265_CR34","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1136\/heartjnl-2012-302535","volume":"99","author":"M Kanbay","year":"2013","unstructured":"Kanbay M, Segal M, Afsar B, Kang D-H, Rodriguez-Iturbe B, Johnson RJ. The role of uric acid in the pathogenesis of human cardiovascular disease. Heart. 2013;99:759\u201366.","journal-title":"Heart"},{"key":"265_CR35","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1016\/j.amjcard.2004.06.032","volume":"94","author":"G Mercuro","year":"2004","unstructured":"Mercuro G, Vitale C, Cerquetani E, Zoncu S, Deidda M, Fini M, et al. Effect of hyperuricemia upon endothelial function in patients at increased cardiovascular risk. Am J Cardiol. 2004;94:932\u20135.","journal-title":"Am J Cardiol"},{"key":"265_CR36","doi-asserted-by":"crossref","unstructured":"Sautin YY, Nakagawa T, Zharikov S, Johnson RJ, Cell JP. Adverse effects of the classic antioxidant uric acid in adipocytes: NADPH oxidase-mediated oxidative\/nitrosative stress. Am J Physiol Cell Physiol. 2007;0224:584\u201396.","DOI":"10.1152\/ajpcell.00600.2006"},{"key":"265_CR37","doi-asserted-by":"publisher","first-page":"1661","DOI":"10.1097\/HJH.0b013e328303205d","volume":"26","author":"A Er\u00e4ranta","year":"2008","unstructured":"Er\u00e4ranta A, Kurra V, Tahvanainen AM, Vehmas TI, K\u00f6\u00f6bi P, Lakkisto P, et al. Oxonic acid-induced hyperuricemia elevates plasma aldosterone in experimental renal insufficiency. J Hypertens. 2008;26:1661\u20138.","journal-title":"J Hypertens"},{"key":"265_CR38","doi-asserted-by":"publisher","first-page":"1811","DOI":"10.1056\/NEJMra0800885","volume":"359","author":"DI Feig","year":"2008","unstructured":"Feig DI, Kang DH, Johnson RJ. Uric acid and cardiovascular risk. N Engl J Med. 2008;359:1811\u201321.","journal-title":"N Engl J Med"},{"key":"265_CR39","doi-asserted-by":"publisher","first-page":"1","DOI":"10.5049\/EBP.2014.12.1.1","volume":"12","author":"DH Kang","year":"2014","unstructured":"Kang DH, Ha SK. Uric acid puzzle: dual role as anti-oxidantand pro-oxidant. Electrolyte Blood Press. 2014;12:1\u20136.","journal-title":"Electrolyte Blood Press"},{"key":"265_CR40","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1113\/jphysiol.2003.055913","volume":"555","author":"CE Berry","year":"2004","unstructured":"Berry CE, Hare JM. Xanthine oxidoreductase and cardiovascular disease: molecular mechanisms and pathophysiological implications. J Physiol. 2004;555:589\u2013606.","journal-title":"J Physiol"},{"key":"265_CR41","doi-asserted-by":"publisher","first-page":"1752","DOI":"10.1172\/JCI21625","volume":"114","author":"S Furukawa","year":"2004","unstructured":"Furukawa S, Fujita T, Shimabukuro M, Iwaki M, Yamada Y, Nakajima Y, et al. Increased oxidative stress in obesity and its impact on metabolic syndrome. J Clin Invest. 2004;114:1752\u201361.","journal-title":"J Clin Invest"},{"key":"265_CR42","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.2337\/db10-0916","volume":"60","author":"W Baldwin","year":"2011","unstructured":"Baldwin W, McRae S, Marek G, Wymer D, Pannu V, Baylis C, et al. Hyperuricemia as a mediator of the proinflammatory endocrine imbalance in the adipose tissue in a murine model of the metabolic syndrome. Diabetes. 2011;60:1258\u201369.","journal-title":"Diabetes"},{"key":"265_CR43","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1530\/eje.0.1470173","volume":"147","author":"M Matsubara","year":"2002","unstructured":"Matsubara M, Maruoka S, Katayose S. Inverse relationship between plasma adiponectin and leptin concentrations in normal-weight and obese women. Eur J Endocrinol. 2002;147:173\u201380.","journal-title":"Eur J Endocrinol"},{"key":"265_CR44","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.1161\/HYPERTENSIONAHA.107.086835","volume":"49","author":"WS Chow","year":"2007","unstructured":"Chow WS, Cheung BMY, Tso AWK, Xu A, Wat NMS, Fong CHY, et al. Hypoadiponectinemia as a predictor for the development of hypertension: a 5-year prospective study. Hypertension. 2007;49:1455\u201361.","journal-title":"Hypertension"},{"key":"265_CR45","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1210\/jc.2003-031163","volume":"89","author":"Y Yamamoto","year":"2004","unstructured":"Yamamoto Y, Hirose H, Saito I, Nishikai K, Saruta T. Adiponectin, an adipocyte-derived protein, predicts future insulin resistance: two-year follow-up study in Japanese population. J Clin Endocrinol Metab. 2004;89:87\u201390.","journal-title":"J Clin Endocrinol Metab"},{"key":"265_CR46","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1111\/jch.12353","volume":"16","author":"J Zhang","year":"2014","unstructured":"Zhang J, Zhang Y, Deng W, Chen B. Elevated serum uric acid is associated with angiotensinogen in obese patients with untreated hypertension. J Clin Hypertens. 2014;16:569\u201374.","journal-title":"J Clin Hypertens"},{"key":"265_CR47","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1007\/s12020-014-0239-5","volume":"48","author":"J-X Zhang","year":"2014","unstructured":"Zhang J-X, Zhang Y-P, Wu Q-N, Chen B. Uric acid induces oxidative stress via an activation of the renin-angiotensin system in 3T3-L1 adipocytes. Endocrine. 2014;48:135\u201342.","journal-title":"Endocrine"},{"key":"265_CR48","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1016\/j.bbrc.2014.04.080","volume":"447","author":"Y Zhu","year":"2014","unstructured":"Zhu Y, Hu Y, Huang T, Zhang Y, Li Z, Luo C, et al. High uric acid directly inhibits insulin signalling and induces insulin resistance. Biochem Biophys Res Commun. 2014;447:707\u201314.","journal-title":"Biochem Biophys Res Commun"},{"key":"265_CR49","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1253\/circj.69.928","volume":"69","author":"TW Yoo","year":"2005","unstructured":"Yoo TW, Sung KC, Shin HS, Kim BJ, Kim BS, Kang JH, et al. Relationship between serum uric acid concentration and insulin resistance and metabolic syndrome. Circ J. 2005;69:928\u201333.","journal-title":"Circ J"},{"key":"265_CR50","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1093\/aje\/kwg260","volume":"158","author":"MR Carnethon","year":"2003","unstructured":"Carnethon MR, Fortmann SP, Palaniappan L, Duncan BB, Schmidt MI, Chambless LE. Risk factors for progression to incident hyperinsulinemia: the atherosclerosis risk in communities study, 1987\u20131998. Am J Epidemiol. 2003;158:1058\u201367.","journal-title":"Am J Epidemiol"},{"key":"265_CR51","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1016\/j.jacc.2015.06.1328","volume":"66","author":"LS Sperling","year":"2015","unstructured":"Sperling LS, Mechanick JI, Neeland IJ, Herrick CJ, Despr\u00e9s J-P, Ndumele CE, et al. The CardioMetabolic health alliance. J Am Coll Cardiol. 2015;66:1050\u201367.","journal-title":"J Am Coll Cardiol"}],"container-title":["BMC Cardiovascular Disorders"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-016-0265-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12872-016-0265-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-016-0265-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-016-0265-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,24]],"date-time":"2017-06-24T09:15:46Z","timestamp":1498295746000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmccardiovascdisord.biomedcentral.com\/articles\/10.1186\/s12872-016-0265-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5,10]]},"references-count":51,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["265"],"URL":"https:\/\/doi.org\/10.1186\/s12872-016-0265-8","relation":{},"ISSN":["1471-2261"],"issn-type":[{"value":"1471-2261","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,5,10]]},"article-number":"85"}}